214 related articles for article (PubMed ID: 34670127)
1. Evaluation of thrombin generation assay in factor XI deficiency.
Kasonga F; Feugray G; Chamouni P; Barbay V; Fresel M; Chretien MH; Brunel S; Le Cam Duchez V; Billoir P
Clin Chim Acta; 2021 Dec; 523():348-354. PubMed ID: 34670127
[TBL] [Abstract][Full Text] [Related]
2. Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
Pike GN; Cumming AM; Hay CR; Bolton-Maggs PH; Burthem J
Blood; 2015 Jul; 126(3):397-405. PubMed ID: 25911238
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.
Pike GN; Cumming AM; Hay CR; Sempasa B; Sutherland M; Thachil J; Burthem J; Bolton-Maggs PH
Haemophilia; 2016 May; 22(3):403-10. PubMed ID: 26558335
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.
Rugeri L; Quélin F; Chatard B; De Mazancourt P; Negrier C; Dargaud Y
Haemophilia; 2010 Sep; 16(5):771-7. PubMed ID: 20398070
[TBL] [Abstract][Full Text] [Related]
5. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
Colucci M; Incampo F; Cannavò A; Menegatti M; Siboni SM; Zaccaria F; Semeraro N; Peyvandi F
J Thromb Haemost; 2016 Aug; 14(8):1603-14. PubMed ID: 27094709
[TBL] [Abstract][Full Text] [Related]
6. The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency.
Livnat T; Shenkman B; Martinowitz U; Zivelin A; Dardik R; Tamarin I; Mansharov R; Budnik I; Salomon O
Thromb Res; 2015 Aug; 136(2):465-73. PubMed ID: 26160656
[TBL] [Abstract][Full Text] [Related]
7. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.
Zucker M; Seligsohn U; Salomon O; Wolberg AS
J Thromb Haemost; 2014 Jul; 12(7):1121-30. PubMed ID: 24815347
[TBL] [Abstract][Full Text] [Related]
8. Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy.
Bertaggia Calderara D; Zermatten MG; Aliotta A; Batista Mesquita Sauvage AP; Carle V; Heinis C; Alberio L
Thromb Haemost; 2021 Feb; 121(2):150-163. PubMed ID: 32920807
[TBL] [Abstract][Full Text] [Related]
9. Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: A retrospective single-centre study.
Désage S; Dargaud Y; Meunier S; Le Quellec S; Lienhart A; Negrier C; Nougier C; Rugeri L
Haemophilia; 2022 Mar; 28(2):301-307. PubMed ID: 35122661
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency.
Pike GN; Cumming AM; Thachil J; Hay CR; Burthem J; Bolton-Maggs PH
Haemophilia; 2017 Mar; 23(2):273-283. PubMed ID: 27862691
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.
Reitsma SE; Holle LA; Bouck EG; Monroe DM; Mast AE; Burthem J; Bolton-Maggs PHB; Gidley GN; Wolberg AS
J Thromb Haemost; 2023 Mar; 21(3):467-479. PubMed ID: 36696199
[TBL] [Abstract][Full Text] [Related]
12. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
[TBL] [Abstract][Full Text] [Related]
13. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
14. The clinical management of factor XI deficiency in pregnant women.
Wheeler AP; Hemingway C; Gailani D
Expert Rev Hematol; 2020 Jul; 13(7):719-729. PubMed ID: 32437625
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency.
Pike GN; Cumming AM; Thachil J; Hay CRM; Bolton-Maggs PHB; Burthem J
Haemophilia; 2017 May; 23(3):449-457. PubMed ID: 28092924
[TBL] [Abstract][Full Text] [Related]
16. A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation.
Wan J; Tanratana P; Roest M; Gruber A; Pawlinski R; Wolberg AS; Mackman N; Grover SP
Blood Adv; 2023 May; 7(9):1915-1925. PubMed ID: 36583671
[TBL] [Abstract][Full Text] [Related]
17. Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model.
van Montfoort ML; Knaup VL; Marquart JA; Bakhtiari K; Castellino FJ; Hack CE; Meijers JC
Thromb Haemost; 2013 Nov; 110(5):1065-73. PubMed ID: 23925504
[TBL] [Abstract][Full Text] [Related]
18. Epidural/spinal anesthesia during delivery in women with factor XI deficiency, a single center experience.
Shacham Abulafia A; Yaniv Y; Steimatzky A; Orbach-Zinger S; Hadar E; Shmueli A; Borovich A; Ziv E; Rozovski U; Wiznitzer A; Eidelman LA; Raanani P; Spectre G
Haemophilia; 2020 Sep; 26(5):834-839. PubMed ID: 32666626
[TBL] [Abstract][Full Text] [Related]
19. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations.
Lin HY; Lin CY; Hung MH; Kuo SF; Lin JS; Shen MC
Int J Hematol; 2020 Aug; 112(2):169-175. PubMed ID: 32333264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
